NCT04589624View on ClinicalTrials.gov

An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy

PHASE1RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Thyroid Gland Carcinoma
Interventions
DRUG

Hyperpolarized Carbon C 13 Pyruvate

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Magnetic Resonance Imaging

Undergo hpMRI

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT04589624 - An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy | Biotech Hunter | Biotech Hunter